Watch Demo

Aptamers Market Research Report by Type, Application, End-User, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030

Aptamers Market Research Report by Type, Application, End-User, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030
  • Publish Date:January 2023

  • Number of Pages:150

  • Report ID:6385892

  • Format:PDF

  • Publisher:360iResearch

$ 3949

Summary

Aptamers Market Research Report by Type (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers), Application, End-User, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030

The North America Aptamers Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the North America Aptamers Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the North America Aptamers Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the North America Aptamers Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The North America Aptamers Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the North America Aptamers Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the North America Aptamers Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market is studied across DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.

Based on Application, the market is studied across Diagnostics, Research & Development, and Therapeutics Development.

Based on End-User, the market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.

Based on Country, the market is studied across Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the North America Aptamers Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The North America Aptamers Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The North America Aptamers Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The North America Aptamers Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the North America Aptamers Market, including 2bind GmbH, Agilent Technologies, Inc., AMS Biotechnology (Europe) Limited, Aptagen, LLC, Aptamer Group, Aptamer Sciences, Inc., AptaTargets SL, Aptus Biotech S.L., ATDBio Ltd., Base Pair Biotechnologies, Inc., Creative Biogene, IVERIC bio, Inc., Kaneka Corporation, NeoVentures Biotechnology, Inc., NOVAPTECH, Novartis AG, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the North America Aptamers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the North America Aptamers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the North America Aptamers Market?
4. What is the competitive strategic window for opportunities in the North America Aptamers Market?
5. What are the technology trends and regulatory frameworks in the North America Aptamers Market?
6. What is the market share of the leading vendors in the North America Aptamers Market?
7. What modes and strategic moves are considered suitable for entering the North America Aptamers Market?

Table of contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Aptamers Market, by Type
6.1. Introduction
6.2. DNA-Based Aptamers
6.3. RNA-Based Aptamers
6.4. XNA-Based Aptamers

7. Aptamers Market, by Application
7.1. Introduction
7.2. Diagnostics
7.3. Research & Development
7.4. Therapeutics Development

8. Aptamers Market, by End-User
8.1. Introduction
8.2. Academic & Government Research Institutes
8.3. Biotechnology & Pharmaceutical Companies
8.4. Contract Research Organizations

9. Canada Aptamers Market
9.1. Introduction

10. Mexico Aptamers Market
10.1. Introduction

11. United States Aptamers Market
11.1. Introduction

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 2bind GmbH
13.2. Agilent Technologies, Inc.
13.3. AMS Biotechnology (Europe) Limited
13.4. Aptagen, LLC
13.5. Aptamer Group
13.6. Aptamer Sciences, Inc.
13.7. AptaTargets SL
13.8. Aptus Biotech S.L.
13.9. ATDBio Ltd.
13.10. Base Pair Biotechnologies, Inc.
13.11. Creative Biogene
13.12. IVERIC bio, Inc.
13.13. Kaneka Corporation
13.14. NeoVentures Biotechnology, Inc.
13.15. NOVAPTECH
13.16. Novartis AG
13.17. SomaLogic, Inc.
13.18. TAGCyx Biotechnologies Inc.
13.19. Vivonics, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. NORTH AMERICA APTAMERS MARKET: RESEARCH PROCESS
FIGURE 2. NORTH AMERICA APTAMERS MARKET SIZE, 2022 VS 2030
FIGURE 3. NORTH AMERICA APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NORTH AMERICA APTAMERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 5. NORTH AMERICA APTAMERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. NORTH AMERICA APTAMERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 7. NORTH AMERICA APTAMERS MARKET DYNAMICS
FIGURE 8. NORTH AMERICA APTAMERS MARKET PORTER'S FIVE FORCES ANALYSIS
FIGURE 9. NORTH AMERICA APTAMERS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. NORTH AMERICA APTAMERS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. NORTH AMERICA APTAMERS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 12. NORTH AMERICA APTAMERS MARKET SIZE, BY DNA-BASED APTAMERS, 2018-2030 (USD MILLION)
FIGURE 13. NORTH AMERICA APTAMERS MARKET SIZE, BY RNA-BASED APTAMERS, 2018-2030 (USD MILLION)
FIGURE 14. NORTH AMERICA APTAMERS MARKET SIZE, BY XNA-BASED APTAMERS, 2018-2030 (USD MILLION)
FIGURE 15. NORTH AMERICA APTAMERS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 16. NORTH AMERICA APTAMERS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. NORTH AMERICA APTAMERS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 18. NORTH AMERICA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
FIGURE 19. NORTH AMERICA APTAMERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
FIGURE 20. NORTH AMERICA APTAMERS MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, 2018-2030 (USD MILLION)
FIGURE 21. NORTH AMERICA APTAMERS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 22. NORTH AMERICA APTAMERS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. NORTH AMERICA APTAMERS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 24. NORTH AMERICA APTAMERS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 25. NORTH AMERICA APTAMERS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
FIGURE 26. NORTH AMERICA APTAMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
FIGURE 27. CANADA APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 28. MEXICO APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 31. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 32. UNITED STATES APTAMERS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 33. NORTH AMERICA APTAMERS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 34. NORTH AMERICA APTAMERS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 35. NORTH AMERICA APTAMERS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables

TABLE 1. NORTH AMERICA APTAMERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. NORTH AMERICA APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. NORTH AMERICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 5. NORTH AMERICA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. NORTH AMERICA APTAMERS MARKET SIZE, BY DNA-BASED APTAMERS, 2018-2030 (USD MILLION)
TABLE 7. NORTH AMERICA APTAMERS MARKET SIZE, BY DNA-BASED APTAMERS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 8. NORTH AMERICA APTAMERS MARKET SIZE, BY RNA-BASED APTAMERS, 2018-2030 (USD MILLION)
TABLE 9. NORTH AMERICA APTAMERS MARKET SIZE, BY RNA-BASED APTAMERS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 10. NORTH AMERICA APTAMERS MARKET SIZE, BY XNA-BASED APTAMERS, 2018-2030 (USD MILLION)
TABLE 11. NORTH AMERICA APTAMERS MARKET SIZE, BY XNA-BASED APTAMERS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 12. NORTH AMERICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. NORTH AMERICA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 14. NORTH AMERICA APTAMERS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 15. NORTH AMERICA APTAMERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 16. NORTH AMERICA APTAMERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. NORTH AMERICA APTAMERS MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 18. NORTH AMERICA APTAMERS MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. NORTH AMERICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. NORTH AMERICA APTAMERS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 21. NORTH AMERICA APTAMERS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. NORTH AMERICA APTAMERS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 23. NORTH AMERICA APTAMERS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. NORTH AMERICA APTAMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 25. NORTH AMERICA APTAMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. CANADA APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 27. CANADA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. NORTH AMERICA APTAMERS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 40. NORTH AMERICA APTAMERS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 41. NORTH AMERICA APTAMERS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 42. NORTH AMERICA APTAMERS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 43. NORTH AMERICA APTAMERS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 44. NORTH AMERICA APTAMERS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 45. NORTH AMERICA APTAMERS MARKET MERGER & ACQUISITION
TABLE 46. NORTH AMERICA APTAMERS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 47. NORTH AMERICA APTAMERS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 48. NORTH AMERICA APTAMERS MARKET INVESTMENT & FUNDING
TABLE 49. NORTH AMERICA APTAMERS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 50. NORTH AMERICA APTAMERS MARKET: LICENSE & PRICING

Companies Mentioned

2bind GmbH
Agilent Technologies, Inc.
AMS Biotechnology (Europe) Limited
Aptagen, LLC
Aptamer Group
Aptamer Sciences, Inc.
AptaTargets SL
Aptus Biotech S.L.
ATDBio Ltd.
Base Pair Biotechnologies, Inc.
Creative Biogene
IVERIC bio, Inc.
Kaneka Corporation
NeoVentures Biotechnology, Inc.
NOVAPTECH
Novartis AG
SomaLogic, Inc.
TAGCyx Biotechnologies Inc.
Vivonics, Inc.

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.